Fine tuning of agonistic/antagonistic activity for Vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity

Yasuaki Anami, Yuta Sakamaki, Toshimasa Itoh, Yuka Inaba, Makoto Nakabayashi, Teikichi Ikura, Nobutoshi Ito, Keiko Yamamoto

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

1α,25-DihydroxyVitamin D3 exerts its actions by binding to Vitamin D receptor (VDR). We are continuing the study related to the alteration of pocket structure of VDR by 22-alkyl substituent of ligands and the relationships between the alteration and agonistic/antagonistic activity. Previously we reported that compounds 2 (22-H), 3 (22S-Et), and 4 (22S-Bu) are VDR agonist, partial agonist and antagonist, respectively. Here, we describe the synthesis and biological evaluation of 22S-hexyl analog 5 (22S-Hex), which was designed to be a stronger VDR antagonist than 4. Unexpectedly, 5 showed partial agonistic but not antagonistic activity when bound to VDR, indicating that it is not necessarily true that the bulkier the side chain is, the stronger the antagonistic activity will be. X-ray crystallographic analysis of the VDR-ligand-binding domain (VDR-LBD) accommodating compound 5 indicated that the partial agonist activity of 5 is dependent on the mixed population of the agonistic and antagonistic conformations. Binding of compound 5 may not bring the complex into the only antagonistic conformation due to the large conformational change of the VDR-LBD. From this study it was found that fine tuning of agonistic/antagonistic activity for VDR is possible by 22-alkyl chain length of ligands.

Original languageEnglish
Pages (from-to)7274-7281
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume23
Issue number22
DOIs
Publication statusPublished - Nov 15 2015
Externally publishedYes

Fingerprint

Calcitriol Receptors
Chain length
Tuning
Ligands
Conformations
Calcitriol
X-Rays
X rays

Keywords

  • Ligand-binding pocket
  • Nuclear receptor
  • Partial agonist
  • Vitamin D
  • X-ray crystallographic structure

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Fine tuning of agonistic/antagonistic activity for Vitamin D receptor by 22-alkyl chain length of ligands : 22S-Hexyl compound unexpectedly restored agonistic activity. / Anami, Yasuaki; Sakamaki, Yuta; Itoh, Toshimasa; Inaba, Yuka; Nakabayashi, Makoto; Ikura, Teikichi; Ito, Nobutoshi; Yamamoto, Keiko.

In: Bioorganic and Medicinal Chemistry, Vol. 23, No. 22, 15.11.2015, p. 7274-7281.

Research output: Contribution to journalArticle

Anami, Yasuaki ; Sakamaki, Yuta ; Itoh, Toshimasa ; Inaba, Yuka ; Nakabayashi, Makoto ; Ikura, Teikichi ; Ito, Nobutoshi ; Yamamoto, Keiko. / Fine tuning of agonistic/antagonistic activity for Vitamin D receptor by 22-alkyl chain length of ligands : 22S-Hexyl compound unexpectedly restored agonistic activity. In: Bioorganic and Medicinal Chemistry. 2015 ; Vol. 23, No. 22. pp. 7274-7281.
@article{2144ec5708e84581b3394d2fea2a4430,
title = "Fine tuning of agonistic/antagonistic activity for Vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity",
abstract = "1α,25-DihydroxyVitamin D3 exerts its actions by binding to Vitamin D receptor (VDR). We are continuing the study related to the alteration of pocket structure of VDR by 22-alkyl substituent of ligands and the relationships between the alteration and agonistic/antagonistic activity. Previously we reported that compounds 2 (22-H), 3 (22S-Et), and 4 (22S-Bu) are VDR agonist, partial agonist and antagonist, respectively. Here, we describe the synthesis and biological evaluation of 22S-hexyl analog 5 (22S-Hex), which was designed to be a stronger VDR antagonist than 4. Unexpectedly, 5 showed partial agonistic but not antagonistic activity when bound to VDR, indicating that it is not necessarily true that the bulkier the side chain is, the stronger the antagonistic activity will be. X-ray crystallographic analysis of the VDR-ligand-binding domain (VDR-LBD) accommodating compound 5 indicated that the partial agonist activity of 5 is dependent on the mixed population of the agonistic and antagonistic conformations. Binding of compound 5 may not bring the complex into the only antagonistic conformation due to the large conformational change of the VDR-LBD. From this study it was found that fine tuning of agonistic/antagonistic activity for VDR is possible by 22-alkyl chain length of ligands.",
keywords = "Ligand-binding pocket, Nuclear receptor, Partial agonist, Vitamin D, X-ray crystallographic structure",
author = "Yasuaki Anami and Yuta Sakamaki and Toshimasa Itoh and Yuka Inaba and Makoto Nakabayashi and Teikichi Ikura and Nobutoshi Ito and Keiko Yamamoto",
year = "2015",
month = "11",
day = "15",
doi = "10.1016/j.bmc.2015.10.026",
language = "English",
volume = "23",
pages = "7274--7281",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "22",

}

TY - JOUR

T1 - Fine tuning of agonistic/antagonistic activity for Vitamin D receptor by 22-alkyl chain length of ligands

T2 - 22S-Hexyl compound unexpectedly restored agonistic activity

AU - Anami, Yasuaki

AU - Sakamaki, Yuta

AU - Itoh, Toshimasa

AU - Inaba, Yuka

AU - Nakabayashi, Makoto

AU - Ikura, Teikichi

AU - Ito, Nobutoshi

AU - Yamamoto, Keiko

PY - 2015/11/15

Y1 - 2015/11/15

N2 - 1α,25-DihydroxyVitamin D3 exerts its actions by binding to Vitamin D receptor (VDR). We are continuing the study related to the alteration of pocket structure of VDR by 22-alkyl substituent of ligands and the relationships between the alteration and agonistic/antagonistic activity. Previously we reported that compounds 2 (22-H), 3 (22S-Et), and 4 (22S-Bu) are VDR agonist, partial agonist and antagonist, respectively. Here, we describe the synthesis and biological evaluation of 22S-hexyl analog 5 (22S-Hex), which was designed to be a stronger VDR antagonist than 4. Unexpectedly, 5 showed partial agonistic but not antagonistic activity when bound to VDR, indicating that it is not necessarily true that the bulkier the side chain is, the stronger the antagonistic activity will be. X-ray crystallographic analysis of the VDR-ligand-binding domain (VDR-LBD) accommodating compound 5 indicated that the partial agonist activity of 5 is dependent on the mixed population of the agonistic and antagonistic conformations. Binding of compound 5 may not bring the complex into the only antagonistic conformation due to the large conformational change of the VDR-LBD. From this study it was found that fine tuning of agonistic/antagonistic activity for VDR is possible by 22-alkyl chain length of ligands.

AB - 1α,25-DihydroxyVitamin D3 exerts its actions by binding to Vitamin D receptor (VDR). We are continuing the study related to the alteration of pocket structure of VDR by 22-alkyl substituent of ligands and the relationships between the alteration and agonistic/antagonistic activity. Previously we reported that compounds 2 (22-H), 3 (22S-Et), and 4 (22S-Bu) are VDR agonist, partial agonist and antagonist, respectively. Here, we describe the synthesis and biological evaluation of 22S-hexyl analog 5 (22S-Hex), which was designed to be a stronger VDR antagonist than 4. Unexpectedly, 5 showed partial agonistic but not antagonistic activity when bound to VDR, indicating that it is not necessarily true that the bulkier the side chain is, the stronger the antagonistic activity will be. X-ray crystallographic analysis of the VDR-ligand-binding domain (VDR-LBD) accommodating compound 5 indicated that the partial agonist activity of 5 is dependent on the mixed population of the agonistic and antagonistic conformations. Binding of compound 5 may not bring the complex into the only antagonistic conformation due to the large conformational change of the VDR-LBD. From this study it was found that fine tuning of agonistic/antagonistic activity for VDR is possible by 22-alkyl chain length of ligands.

KW - Ligand-binding pocket

KW - Nuclear receptor

KW - Partial agonist

KW - Vitamin D

KW - X-ray crystallographic structure

UR - http://www.scopus.com/inward/record.url?scp=84946208245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946208245&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2015.10.026

DO - 10.1016/j.bmc.2015.10.026

M3 - Article

C2 - 26515040

AN - SCOPUS:84946208245

VL - 23

SP - 7274

EP - 7281

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 22

ER -